Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930 · see citing works

The coagulation cascade: initiation, maintenance, and regulation

Davie, E. W., Fujikawa, K., & Kisiel, W. (1991) · Biochemistry · doi:10.1021/bi00107a001 · Cited by 1,821 · see citing works

Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines

Hassett, K. J., Benenato, K. E., Jacquinet, E., Lee, A., Woods, A., Yuzhakov, O., Himansu, S., Deterling, J., Geilich, B. M., Ketova, T., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.01.013 · Cited by 927 · see citing works

Emerging issues in AAV-mediated in vivo gene therapy

Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881 · see citing works

A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates

Sabnis, S., Kumarasinghe, E. S., Salerno, T., Mihai, C., Ketova, T., Senn, J. J., Lynn, A., Bulychev, A., McFadyen, I., Chan, J., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.03.010 · Cited by 820 · see citing works

AAV5–Factor VIII Gene Transfer in Severe Hemophilia A

Rangarajan, S., Walsh, L., Lester, W., Perry, D., Madan, B., Laffan, M., Yu, H., Vettermann, C., Pierce, G. F., Wong, W. Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708483 · Cited by 694 · see citing works

AAV vector integration sites in mouse hepatocellular carcinoma

Donsante, A., Miller, D. G., Li, Y., Vogler, C., Brunt, E. M., Russell, D. W., & Sands, M. S. (2007) · Science · doi:10.1126/science.1142658 · Cited by 662 · see citing works

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

Ehrenforth, S., Kreuz, W., LINDE, R. W. T., Funk, M. B., Güngör, T., Krackhardt, B., Kornhuber, B., & Scharrer, I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90874-3 · Cited by 603 · see citing works

Lipid nanoparticles enabling gene therapies: from concepts to clinical utility

Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592 · see citing works

A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors

Young, G. A., Liesner, R. J., Chang, T. Y., Sidonio, R. F., Oldenburg, J., Jiménez‐Yuste, V., Mahlangu, J. N., Kruse‐Jarres, R., Wang, M., Uguen, M., et al. (2019) · Blood · doi:10.1182/blood.2019001869 · Cited by 406 · see citing works

Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy

Chandler, R. J., LaFave, M. C., Varshney, G. K., Trivedi, N. S., Carrillo-Carrasco, N., Senac, J. S., Wu, W., Hoffmann, V., Elkahloun, A. G., Burgess, S. M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79213 · Cited by 403 · see citing works

Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.

Kaufman, R. J., Wasley, L. C., & Dorner, A. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68793-9 · Cited by 388 · see citing works

A critical analysis of codon optimization in human therapeutics

Mauro, V. P., & Chappell, S. A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.003 · Cited by 343 · see citing works

Systemic delivery of factor IX messenger RNA for protein replacement therapy

Ramaswamy, S., Tonnu, N., Tachikawa, K., Limphong, P., Vega, J. B., Karmali, P. P., Chivukula, P., & Verma, I. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619653114 · Cited by 301 · see citing works

Elevated factor VIII levels and risk of venous thrombosis

Jenkins, P. V., Rawley, O., Smith, O. P., & O’Donnell, J. S. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09134.x · Cited by 283 · see citing works

Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes

Judge, A. D., McClintock, K., Phelps, J. R., & MacLachlan, I. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.014 · Cited by 280 · see citing works

Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia

An, D., Schneller, J. L., Frassetto, A., Liang, S., Zhu, X., Park, J.-S., Theisen, M., Hong, S.-J., Zhou, J., Rajendran, R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.081 · Cited by 263 · see citing works

Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification

Vaidyanathan, S., Azizian, K. T., Haque, A. K. M. A., Henderson, J. M., Hendel, A., Shore, S., Antony, J. S., Hogrefe, R. I., Kormann, M. S. D., Porteus, M. H., et al. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.010 · Cited by 262 · see citing works

Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells

Dorner, A. J., Wasley, L. C., & Kaufman, R. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47105-6 · Cited by 259 · see citing works

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients

Powell, J. S., Josephson, N. C., Quon, D. V. K., Ragni, M. V., Cheng, G. Y.-M., Li, E., Jiang, H., Li, L., Dumont, J. A., Goyal, J., et al. (2012) · Blood · doi:10.1182/blood-2011-09-382846 · Cited by 242 · see citing works

Bioengineering of coagulation factor VIII for improved secretion

Miao, H. Z., Sirachainan, N., Palmer, L. E., Kucab, P., Cunningham, M. A., Kaufman, R. J., & Pipe, S. W. (2004) · Blood · doi:10.1182/blood-2003-10-3591 · Cited by 209 · see citing works

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes

Gan, L., Fermer, M. L., Carlsson, L. G., Arfvidsson, C., Egnell, A., Rudvik, A., Kjaer, M., Collén, A., Thompson, J. D., Joyal, J. L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08852-4 · Cited by 209 · see citing works

Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine

Kwon, H., Kim, M., Seo, Y., Moon, Y. S., Lee, H. J., Lee, K., & Lee, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.034 · Cited by 208 · see citing works

Stabilized plasmid–lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression

Ambegia, E., Ansell, S. M., Cullis, P. R., Heyes, J. A., Palmer, L., & MacLachlan, I. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.02.001 · Cited by 203 · see citing works

Codon optimization of human factor VIII cDNAs leads to high-level expression

Ward, N. J., Buckley, S. M. K., Waddington, S. N., VandenDriessche, T., Chuah, M., Nathwani, A. C., McIntosh, J., Tuddenham, E. G. D., Kinnon, C., Thrasher, A. J., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282707 · Cited by 184 · see citing works

Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system

DeRosa, F., Guild, B., Karve, S., Smith, L., Love, K., Dorkin, J. R., Kauffman, K. J., Zhang, J., Yahalom, B., Anderson, D. G., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.46 · Cited by 159 · see citing works

Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs

Dumont, J. A., Liu, T., Low, S. C., Zhang, X., Kamphaus, G. D., Sakorafas, P., Fraley, C., Drager, D., Reidy, T., McCue, J. T., et al. (2012) · Blood · doi:10.1182/blood-2011-08-367813 · Cited by 154 · see citing works

Sequences in the Coding Region of Clotting Factor VIII Act as Dominant Inhibitors of RNA Accumulation and Protein Production

Lynch, C. M., Israel, D. I., Kaufman, R. J., & Miller, A. D. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.3-259 · Cited by 132 · see citing works

Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.

Dwarki, V., Belloni, P., Nijjar, T., Smith, J. D., Couto, L. B., Rabier, M. J., Clift, S., Berns, A. J. M., & Cohen, L. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1023 · Cited by 110 · see citing works

Outcome of Clinical Trials with New Extended Half-Life FVIII/IX Concentrates

Mancuso, M. E., & Santagostino, E. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6040039 · Cited by 108 · see citing works

Patterns of scAAV Vector Insertion Associated With Oncogenic Events in a Mouse Model for Genotoxicity

Rosas, L. E., Grieves, J. L., Zaraspe, K., Perle, K. M. D. L., Fu, H., & McCarty, D. M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.197 · Cited by 95 · see citing works

Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches?

Lieuw, K. H. (2017) · Journal of Blood Medicine · doi:10.2147/jbm.s103796 · Cited by 94 · see citing works

Recommendations on multidisciplinary management of elective surgery in people with haemophilia

Escobar, M. A., Brewer, A., Caviglia, H. A., et al. (2018) · Haemophilia · doi:10.1111/hae.13549 · Cited by 81 · see citing works

Intraosseous Delivery of Lentiviral Vectors Targeting Factor VIII Expression in Platelets Corrects Murine Hemophilia A

Wang, X., Shin, S. C., Chiang, A. F. J., Khan, I., Pan, D., Rawlings, D. J., & Miao, C. H. (2015) · Molecular Therapy · doi:10.1038/mt.2015.20 · Cited by 80 · see citing works

How to discuss gene therapy for haemophilia? A patient and physician perspective

Miesbach, W., O’Mahony, B., Key, N. S., & Makris, M. (2019) · Haemophilia · doi:10.1111/hae.13769 · Cited by 77 · see citing works

Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia

Thorat, T., Neumann, P. J., & Chambers, J. D. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.7.632 · Cited by 75 · see citing works

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

Wada, H., Matsumoto, T., & Katayama, N. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1712683 · Cited by 74 · see citing works

Naked DNA Transfer of Factor VIII Induced Transgene-Specific, Species-Independent Immune Response in Hemophilia A Mice

Ye, P., Thompson, A. R., Sarkar, R., Shen, Z., Lillicrap, D., Kaufman, R. J., Ochs, H. D., Rawlings, D. J., & Miao, C. H. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.04.009 · Cited by 70 · see citing works

mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency

Cao, J., An, D., Galduroz, M., Zhuo, J., Liang, S., Eybye, M., Frassetto, A., Kuroda, E., Funahashi, A., Santana, J., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.04.017 · Cited by 70 · see citing works

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A

Calvez, T., Chambost, H., d’Oiron, R., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.174706 · Cited by 63 · see citing works

Hemophilia gene therapy comes of age

George, L. A. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017009878 · Cited by 62 · see citing works

Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model.

Sabatino, D., Freguia, C., Toso, R., Santos, A., Merricks, E., Kazazian, H., Nichols, T., Camire, R., & Arruda, V. (2009) · Blood · doi:10.1182/blood-2009-05-220327 · Cited by 61 · see citing works

Current and emerging factor VIII replacement products for hemophilia A

Cafuir, L. A., & Kempton, C. L. (2017) · Therapeutic Advances in Hematology · doi:10.1177/2040620717721458 · Cited by 60 · see citing works

Hemophilia gene therapy comes of age

George, L. A. (2017) · Hematology · doi:10.1182/asheducation-2017.1.587 · Cited by 58 · see citing works

Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice

Peng, B., Ye, P., Blazar, B. R., Freeman, G. J., Rawlings, D. J., Ochs, H. D., & Miao, C. H. (2008) · Blood · doi:10.1182/blood-2008-01-128413 · Cited by 54 · see citing works

Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays

Kızılocak, H., Yukhtman, C. L., Marquez‐Casas, E., et al. (2019) · Therapeutic Advances in Hematology · doi:10.1177/2040620719860025 · Cited by 54 · see citing works

Incorporation of the factor IX Padua mutation into FIX-Triple improves clotting activity in vitro and in vivo

Kao, C., Yang, S.-J., Tao, M., Jeng, Y., Yu, I., & Lin, S. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0154 · Cited by 50 · see citing works

Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A

Nguyen, G. N., George, L. A., Siner, J. I., Davidson, R. J., Zander, C. B., Zheng, X. L., Arruda, V. R., Camire, R. M., & Sabatino, D. E. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13543 · Cited by 50 · see citing works

Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIII

Kreuz, W., Becker, S., Lenz, E., et al. (1995) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1000659 · Cited by 48 · see citing works

Biological considerations of plasma-derived and recombinant factor VIII immunogenicity

Lai, J. D., Hough, C. A., Tarrant, J., & Lillicrap, D. (2017) · Blood · doi:10.1182/blood-2016-11-750885 · Cited by 48 · see citing works

ATP-Dependent Dissociation of Non-Disulfide-Linked Aggregates of Coagulation Factor VIII Is a Rate-Limiting Step for Secretion

Tagliavacca, L., Wang, Q., & Kaufman, R. J. (2000) · Biochemistry · doi:10.1021/bi991896r · Cited by 40 · see citing works

Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy

Biasco, L., Rothe, M., Büning, H., & Schambach, A. (2017) · Molecular Therapy: Methods & Clinical Development · doi:10.1016/j.omtm.2017.10.002 · Cited by 35 · see citing works

Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA

Russick, J., Delignat, S., Milanov, P., Christophe, O. D., Boros, G., Denis, C. V., Lenting, P. J., Kaveri, S. V., & Lacroix‐Desmazes, S. (2019) · Haematologica · doi:10.3324/haematol.2018.210583 · Cited by 31 · see citing works

FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity

Ettinger, R. A., Liberman, J. A., Gunasekera, D., Puranik, K., James, E. A., Thompson, A. R., & Pratt, K. P. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017013482 · Cited by 30 · see citing works

Long‐term tolerance to factor VIII is achieved by administration of interleukin‐2/interleukin‐2 monoclonal antibody complexes and low dosages of factor VIII

Liu, C.-L., Ye, P., Lin, J., Djukovic, D., & Miao, C. H. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12576 · Cited by 29 · see citing works

A factor VIII–nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation

Muczynski, V., Casari, C., Moreau, F., et al. (2018) · Blood · doi:10.1182/blood-2018-01-829523 · Cited by 29 · see citing works

Combined Effects of Androgen and Growth Hormone on Osteoblast Marker Expression in Mouse C2C12 and MC3T3-E1 Cells Induced by Bone Morphogenetic Protein

Kimura, K., Terasaka, T., Iwata, N., Katsuyama, T., Komatsubara, M., Nagao, R., Inagaki, K., & Otsuka, F. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6010006 · Cited by 19 · see citing works

Evaluating the safety of emicizumab in patients with hemophilia A

Langer, A. L., Etra, A. M., & Aledort, L. M. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1551356 · Cited by 19 · see citing works

The F309S mutation increases factor VIII secretion in human cell line

Fantacini, D. M. C., Fontes, A. M., Abreu-Neto, M. S., et al. (2016) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1016/j.bjhh.2016.04.002 · Cited by 9 · see citing works

Outcome of perioperative hemostatic management in patients with hemophilia without inhibitors undergoing 161 invasive or surgical procedures

Tong, K., Wang, J., Chang, S., et al. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2017.11.016 · Cited by 8 · see citing works

Molecular Biological Aspects of Inhibitor Development

Tuddenham, E. G. D. (1999) · Vox Sanguinis · doi:10.1159/000056707 · Cited by 7 · see citing works

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141

Importance of RNA isolation methods for analysis of exosomal RNA: Evaluation of different methods

Eldh, M., Lötvall, J. O., Malmhäll, C., & Ekström, K. M. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.02.001 · Cited by 227 · see citing works

Polyadenylic acid on poliovirus RNA. II. poly(A) on intracellular RNAs

Spector, D. H., & Baltimore, D. (1975) · Journal of Virology · doi:10.1128/jvi.15.6.1418-1431.1975 · Cited by 86 · see citing works

The Effect of Formaldehyde Fixation on RNA

Evers, D. L., Fowler, C. B., Cunningham, B. R., Mason, J. T., & O’Leary, T. J. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.01.010 · Cited by 127 · see citing works

Paraffin Embedding Contributes to RNA Aggregation, Reduced RNA Yield, and Low RNA Quality

Evers, D. L., He, J., Kim, Y. H., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.06.007 · Cited by 64 · see citing works